Statute Details
- Title: Merchant Shipping (Medical Stores) Regulations
- Act Code: MSA1995-RG3
- Legislative Type: Subsidiary legislation (SL)
- Authorising Act: Merchant Shipping Act (Chapter 179, Sections 73 and 216)
- Revised Edition: 1997 RevEd (15 June 1997)
- Gazette Citation: G.N. No. S 56/1996 (made 2 February 1996)
- Status (as provided): Current version as at 27 Mar 2026
- Key Subject Matter: Mandatory carriage, standards, storage, inspection, and offences relating to medicines and medical stores on Singapore ships
- Key Sections (high level): Definitions (s 2); Application (s 3); Scales by voyage type (ss 4–6); Ships without doctors (s 7); Morphine controls (s 8); Quantities (s 9); Inspection and pharmacist certification (s 10); Chemical cargo medical stores (s 11); Additional supplies for doctor-crewed voyages (s 12); Standards (s 13); Packaging/label requirements (s 14); Storage and replenishment (ss 15–16); Offences and exemptions (ss 17–18)
- Schedules: First Schedule (scales and detailed lists); Second Schedule (antidotes/ancillary equipment for chemicals); Third Schedule (malaria areas); Fourth Schedule (legislative history)
What Is This Legislation About?
The Merchant Shipping (Medical Stores) Regulations (“Medical Stores Regulations”) set out a detailed compliance framework requiring ships to carry specified medicines and medical stores. The core policy is straightforward: if a ship is at sea, there must be adequate medical supplies available to respond to illness or injury, even when medical personnel are limited or absent.
The Regulations distinguish between different operational contexts—such as foreign-going voyages, home-trade voyages, and “special limit” voyages—and require different “scales” of medical stores depending on the route and the number of persons on board. They also address particular risks: for example, ships carrying chemicals must carry additional antidotes and ancillary equipment, and ships without a qualified doctor must carry a locked “doctor’s attache case” containing certain medicines reserved for doctor use.
For practitioners, the Regulations are important not only because they mandate carriage, but also because they impose standards for the quality of medicines, rules for packaging and labelling, inspection and certification by a registered pharmacist, and criminal liability for contraventions by the ship owner. The Regulations therefore operate as both a safety regime and an enforcement mechanism under the Merchant Shipping Act.
What Are the Key Provisions?
1. Definitions and scope (ss 2–3)
Section 2 defines key terms that drive compliance: “foreign-going ship,” “home-trade ship,” “home-trade voyage,” “special limit voyage,” “malarial areas,” and “chemical.” The definition of “chemical” is anchored to International Maritime Organization (IMO) publications (including dangerous goods indices and liquefied gas construction/equipment codes), meaning the medical obligations can change as international lists are updated.
Section 3 provides that the Regulations apply to all Singapore ships. This is critical for owners and operators: even if a vessel’s trading pattern is narrow, the Regulations still govern carriage of medical stores unless an exemption is granted under s 18.
2. Medical stores by voyage type and passenger numbers (ss 4–6)
For foreign-going ships, s 4 requires carriage according to Scale IA where the number of persons on board does not exceed 30. If more than 30 persons are carried, s 4(2) requires additional sets of items listed in Scale IB for each additional 30 persons (or part thereof).
For home-trade ships, s 5 requires carriage according to Scale II.
For ships plying within special limit from the Port of Singapore, s 6 requires carriage according to Scale III.
Practically, these provisions require owners to map the vessel’s trading pattern to the correct scale and to verify headcount thresholds. Compliance failures often arise from incorrect categorisation of voyage type or miscounting “persons on board” (which typically includes crew and passengers, depending on how the ship’s documentation treats the term).
3. Ships without a qualified doctor: the “doctor’s attache case” (s 7)
Section 7 is one of the most operationally significant provisions. It applies where a ship going to sea carries more than 12 passengers but does not have a qualified doctor as a crew member. In that case, the ship must carry, in addition to the main scale required under ss 4–6, the medicines specified in Scale V (Part 5 of the First Schedule).
Crucially, s 7(2) requires that all medicines under Scale V be kept in a doctor’s attache case. The Regulations then specify handling and security controls: items that cannot be included should be strapped to the case or kept adjacent; the case must be locked; the key must be kept by the master or a nominated person; and the case must be kept in a locked cabinet. The case must also be clearly labelled with a warning that the medicines are to be used only by a qualified doctor or someone under a doctor’s direct supervision on board.
This structure creates a compliance “chain of custody.” Owners and masters should ensure that the case is physically secured, access is controlled, and staff understand that these medicines are not for general use.
4. Morphine controls and record-keeping (s 8)
Section 8 governs the obtaining, use, and disposal of morphine from the doctor’s attache case. It requires that such activities be recorded in the ship’s controlled Drug Register in accordance with the Ship Captain’s Medical Guide. This is a compliance and audit trail requirement: even where morphine is carried lawfully, failure to record use/disposal can create regulatory exposure.
5. Quantity is fixed by the scale, not by voyage length (s 9)
Section 9 provides that the quantity of medicines and medical stores to be kept on board is as prescribed in the First Schedule regardless of the length of voyage. This prevents a common misconception that short voyages require fewer supplies. For counsel advising owners, this means that risk assessments cannot be used to justify reduced carriage below the statutory scale.
6. Inspection and pharmacist certification (s 10)
Section 10 requires that medicines and medical stores be inspected at least once in every 12 months by a registered pharmacist. If the pharmacist is satisfied that the ship is provided in accordance with the appropriate scale, the pharmacist must issue a certificate to that effect.
This provision is important for enforcement readiness. Owners should ensure that certificates are obtained on time, retained for inspection, and that the inspection covers both quantity and condition (including expiry and suitability) consistent with the scale requirements.
7. Chemical cargo: additional antidotes and ancillary equipment (s 11) and schedules (Second Schedule)
Section 11 addresses ships carrying chemicals as whole or part of cargo, or residues of chemicals from earlier voyages. Such ships must carry medicines and medical stores set out in Scale IV in the First Schedule, in the quantities specified.
In addition, s 11(2) requires the ship to carry the required type of medicines and medical stores specified in the Second Schedule as antidote and ancillary equipment for the chemical. The required additional quantity must be that specified in the Chemicals Supplement to the Ship Captain’s Medical Guide or the IMO Medical First Aid Guide.
This is a technically complex compliance area because it requires cross-referencing: (i) the chemical classification, (ii) the relevant antidote/ancillary equipment list, and (iii) the quantity supplement guidance. Practitioners should treat this as a “document control” exercise and ensure the ship’s medical stores plan is aligned with the cargo manifest and the applicable chemical supplement.
8. Additional supplies when a qualified doctor is carried (s 12)
Where a qualified doctor is carried as a member of the crew, s 12 requires additional supplies which the doctor may reasonably require, having regard to the size of the crew, number of passengers, and intended voyage. This provision introduces a reasonableness standard and a professional judgement element, but it still creates a legal obligation to carry additional supplies beyond the baseline scales.
9. Standards, packaging, labelling, storage, and replenishment (ss 13–16)
Section 13 requires that medicines and other medical stores conform to standards in the current editions of recognised pharmacopoeias and formularies (British National Formulary, British Pharmacopoeia, European Pharmacopoeia, United States Pharmacopoeia), and to requirements/specifications in the First and Fourth Schedules.
Section 14 imposes packaging and labelling requirements. It requires labels in English with particulars specified in the First Schedule, and includes specific technical conditions for certain categories (e.g., reclosable containers for tablets/capsules to prevent moisture ingress; disinfectant containers not showing deleterious reaction after six months in normal conditions; insecticides being air-tight and water-tight, packed in sturdy cases, and pressure canisters having valve protection against accidental opening).
Section 15 requires medicines to be stored in accordance with instructions on their containers. Section 16 (as indicated in the metadata) addresses replenishment of dated medicines, which is essential to ensure that supplies remain within expiry/use-by constraints and remain compliant at the time of inspection.
10. Offences and exemptions (ss 17–18)
Section 17 provides that if any provision is contravened, the owner of the ship shall be guilty of an offence. This owner-focused liability is significant: it means that compliance failures by crew or contractors may still trigger criminal exposure for the owner, unless an exemption applies or a defence is available under general principles.
Section 18 empowers the Director to exempt any person or ship (or description of persons or ships) from all or any of the Regulations. For counsel, this is a practical route where operational realities make strict compliance impracticable, but it requires formal application and careful documentation of the exemption scope.
How Is This Legislation Structured?
The Regulations are structured as a short, operational code with:
• Section 1 (Citation); • Section 2 (Definitions); • Section 3 (Application); • Sections 4–6 (medical stores scales for foreign-going, home-trade, and special limit voyages); • Section 7 (ships without qualified doctors and the doctor’s attache case); • Section 8 (morphine record-keeping); • Section 9 (quantity fixed by scale); • Section 10 (annual inspection and pharmacist certificate); • Section 11 (chemical cargo medical stores and antidote/ancillary equipment); • Section 12 (additional supplies when a doctor is on board); • Sections 13–16 (standards, packaging/label, storage, and replenishment); • Sections 17–18 (offences and exemptions).
They are supported by multiple schedules: the First Schedule contains the detailed scales and lists; the Second Schedule contains antidote and ancillary equipment requirements for chemicals; and the Third Schedule specifies “malarial areas,” which likely affects the inclusion of relevant prophylactic or treatment items within the scales. The Fourth Schedule relates to legislative history as provided.
Who Does This Legislation Apply To?
The Regulations apply to all Singapore ships. In practice, this means ship owners, operators, and masters must ensure that the vessel carries the required medical stores for its trading pattern and passenger/crew composition.
Although the Regulations impose criminal liability on the owner for contraventions (s 17), compliance is operationally implemented by the master and crew (e.g., maintaining the doctor’s attache case, controlled drug register entries, and storage/label compliance). Owners should therefore ensure contractual and internal governance arrangements allocate responsibility for procurement, inspection, and record-keeping.
Why Is This Legislation Important?
First, the Regulations create a legally enforceable baseline for maritime medical readiness. By prescribing exact scales and quantities, they reduce ambiguity and ensure that ships cannot substitute “reasonable efforts” for statutory minimums. This is especially important in emergencies where medical supplies must be immediately available and appropriate to the risk profile.
Second, the Regulations embed compliance controls that support enforcement and auditability: annual inspection by a registered pharmacist with a certificate (s 10), controlled record-keeping for morphine (s 8), and detailed packaging/label/storage requirements (ss 14–15). These provisions help authorities and insurers assess whether a ship’s medical stores are not only present but also suitable and properly managed.
Third, the chemical cargo provisions (s 11 and the Second Schedule) reflect the reality that certain cargoes require specialised antidotes and ancillary equipment. For owners and charterers, this means medical stores planning must be integrated into cargo acceptance and voyage preparation, not treated as a generic shipboard stock issue.
Related Legislation
- Merchant Shipping Act (Chapter 179) (authorising provisions: Sections 73 and 216)
- IMO Medical First Aid Guide (referenced for chemical supplement guidance)
- International Maritime Dangerous Goods Code (referenced indirectly through the definition of “chemical”)
- British National Formulary / British Pharmacopoeia / European Pharmacopoeia / United States Pharmacopoeia (standards incorporated by reference in s 13)
Source Documents
This article provides an overview of the Merchant Shipping (Medical Stores) Regulations for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.